See also this year's filing and all EDGAR filings for this company.
PDF Report 0001822462_2022_Foghorn_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001822462, Foghorn Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 459,562,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 60,212,000 |
| 4 | LiabilitiesCurrent | 48,692,000 |
| 5 | LiabilitiesNoncurrent | 374,211,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 21,728,000 |
| 9 | ResearchAndDevelopmentExpense | 80,325,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,319,000 |
| 12 | remainder_NetIncome | -586,000 |
| 13 | remainder_ComprehensiveNetIncome | -3,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 519,774,000 |
| 1 | Liabilities | 422,903,000 |
| 2 | Expenses | 102,053,000 |
| 3 | Revenues | 1,319,000 |
| 4 | StockholdersEquity | 96,871,000 |
| 5 | NetIncome | -101,320,000 |
| 6 | ComprehensiveNetIncome | -101,321,500 |
| 7 | BaseVar | 523,319,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.233 |
| 9 | EconomicCapitalRatio | 1.64 |
Edgar->Model Mapping
Feature Distribution
Change over Time
